China has introduced its first artificial intelligence (AI) powered digital doctor platform focused on Parkinson’s disease, as the country grapples with a rising burden of age-related illnesses.
Developed by the Xuanwu Hospital of Capital Medical University, the platform is designed to ease patient management by reducing repeated consultations and improving access to trusted medical information.
It integrates over 20 years of the hospital’s clinical research with medical records, academic studies, reports, educational resources, and peer-reviewed global literature.
READ ALSO: China Urges Collaboration to Implement UN Sustainable Goals
According to Chen Biao, director of the hospital’s Parkinson’s disease clinical research and treatment centre, the AI system is capable of handling up to 90 per cent of routine patient enquiries.
This allows physicians to dedicate more time to complex cases requiring specialised care.
Accessible via smartphones, the platform enabled patients to ask questions about Parkinson’s disease and receive evidence-based responses.
However, it did not provide individualised treatment recommendations, ensuring that medical decisions remain under the supervision of qualified doctors.
The service also connects users directly to the hospital’s online system for appointment scheduling and prescription services.
Developers say future updates will integrate wearable devices to support medication management, rehabilitation exercises, daily care and mental health support, aiming to create a more comprehensive, long-term care model for patients.
NAN
